Paul Praino.

LOS ANGELES—Eyenuk, a global artificial intelligence (AI) digital health company and leader in real-world applications for AI eye screening and AI predictive biomarkers, along with its board of directors, has announced the appointment of Paul Praino as interim chief executive officer, effective immediately. Praino has been Eyenuk's chief commercial officer since February 2023. Kaushal Solanki, PhD, founder and CEO of Eyenuk, is stepping down from his position after 14 years of building the organization, the company stated. Solanki will continue to support Eyenuk in a special advisory role, contributing to strategic initiatives, and will remain on the board of directors, according to the announcement.

"We extend our heartfelt gratitude to Kaushal for founding Eyenuk and for his unwavering commitment to our mission of eliminating preventable blindness," said Rob Binney, executive chairman of Eyenuk. "Kaushal has been the driving force behind our formidable platform of products and solutions as well as an impressive client base, and his leadership has been instrumental in building the strong team that we have today."

Solanki added, "It has been a rewarding journey founding a mission-driven healthcare AI company almost 14 years back and bringing it to today, where our products are being used in 18 countries across five continents. I am proud of what we have achieved and would like to thank everyone who has taken the journey with me over the years, including the stellar team, all the investors, and numerous esteemed physicians across the globe who believed in the technology's potential to have a tangible impact on public health."

 
Before joining Eyenuk, Praino led the sales team for Alydia Health (acquired by Organon), where he introduced the Jada technology for postpartum hemorrhage to the women's health community. Prior to Alydia, Praino served as global vice president of sales at Intersect ENT.

"I am honored to build on the remarkable achievements that Kaushal and the Eyenuk team have accomplished. Our innovative platform, impressive client base, and dedicated team position us well to continue delivering impactful solutions to patients. I am excited to lead the team during this transition phase and to drive our strategic vision of eliminating preventable blindness," said Praino.

Commenting on the interim appointment of Praino, Binney said, "We are delighted that Paul has agreed to serve as Interim CEO as we search for a permanent CEO. His extensive experience in operational management, healthcare IT, and sales, along with his deep understanding of Eyenuk's solutions and client base, make him the ideal leader for this transition period."